The mechanism of Yinchenhao decoction in treating obstructivejaundice- induced liver injury based on Nrf2 signaling pathway

BACKGROUND Obstructive jaundice(OJ)is caused by bile excretion disorder after partial or complete bile duct obstruction.It may cause liver injury through various mechanisms.Traditional Chinese medicine(TCM)has a lot of advantages in treating OJ.The recovery of liver function can be accelerated by combining Chinese medicine treatment with existing clinical practice.Yinchenhao decoction(YCHD),a TCM formula,has been used to treat jaundice.Although much progress has been made in recent years in understanding the mechanism of YCHD in treating OJ-induced liver injury,it is still not clear.AIM To investigate chemical components of YCHD that are effective in the treatment of OJ and predict the mechanism of YCHD.METHODS The active components and putative targets of YCHD were predicted using a network pharmacology approach.Gene Ontology biological process and Kyoto Encyclopedia of Genes and Genomes path enrichment analysis were carried out by cluster profile.We predicted the biological processes,possible targets,and associated signaling pathways that YCHD may involve in the treatment of OJ.Thirty male Sprague–Dawley rats were randomly divided into three groups,each consisting of 10 rats:the sham group(Group S),the OJ model group(Group M),and the YCHDtreated group(Group Y).The sham group only received laparotomy.The OJ model was established by ligating the common bile duct twice in Groups M and Y.For 1 wk,rats in Group Y were given a gavage of YCHD(3.6 mL/kg)twice daily,whereas rats in Groups S and M were given the same amount of physiological saline after intragastric administration daily.After 7 d,all rats were killed,and the liver and blood samples were collected for histopathological and biochemical examinations.Total bilirubin(TBIL),direct bilirubin(DBIL),alanine aminotransferase(ALT),and aspartate transaminase(AST)levels in the blood samples were detected.The gene expression levels of inducible nitric oxide synthase(iNOS)and endothelial nitric oxide synthase(eNOS),and the nucleus positive rate of NF-E2 related factor 2(Nrf2)protein were measured.Western blot analyses were used to detect the protein and gene expression levels of Nrf2,Kelchlike ECH-associated protein 1,NAD(P)H quinone dehydrogenase 1(NQO1),and glutathione-Stransferase(GST)in the liver tissues.One-way analysis of variance was used to evaluate the statistical differences using the statistical package for the social sciences 23.0 software.Intergroup comparisons were followed by the least significant difference test and Dunnett’s test.RESULTS The effects of YCHD on OJ involve biological processes such as DNA transcription factor binding,RNA polymerase II specific regulation,DNA binding transcriptional activator activity,and nuclear receptor activity.The protective effects of YCHD against OJ were closely related to 20 pathways,including the hepatitis-B,the mitogen-activated protein kinase,the phosphatidylinositol 3-kinase/protein kinase B,and tumor necrosis factor signaling pathways.YCHD alleviated the swelling and necrosis of hepatocytes.Following YCHD treatment,the serum levels of TBIL(176.39±17.03μmol/L vs 132.23±13.88μmol/L,P<0.01),DBIL(141.41±14.66μmol/L vs 106.43±10.88μmol/L,P<0.01),ALT(332.07±34.34 U/L vs 269.97±24.78 U/L,P<0.05),and AST(411.44±47.64 U/L vs 305.47±29.36 U/L,P<0.01)decreased.YCHD promoted the translocation of Nrf2 into the nucleus(12.78±0.99%vs 60.77±1.90%,P<0.001).After YCHD treatment,we found a decrease in iNOS(0.30±0.02 vs 0.20±0.02,P<0.001)and an increase in eNOS(0.18±0.02 vs 0.32±0.02,P<0.001).Meanwhile,in OJ rats,YCHD increased the expressions of Nrf2(0.57±0.03 vs 1.18±0.10,P<0.001),NQO1(0.13±0.09 vs 1.19±0.07,P<0.001),and GST(0.12±0.02 vs 0.50±0.05,P<0.001),implying that the potential mechanism of YCHD against OJ-induced liver injury was the upregulation of the Nrf2 signaling pathway.CONCLUSION OJ-induced liver injury is associated with the Nrf2 signaling pathway.YCHD can reduce liver injury and oxidative damage by upregulating the Nrf2 pathway.